Express Scripts Holding Company Announces Second Quarter 2015 Earnings Conference Call

ST. LOUIS, July 6, 2015 (GLOBE NEWSWIRE) -- Express Scripts Holding Company ESRX announced today its intention to release its second quarter earnings on Tuesday, July 28, 2015 after the market closes and will hold its quarterly conference call to discuss second quarter results on Wednesday, July 29, 2015, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time).

This call is being webcast and can be accessed at the Investor Information section of Express Scripts' web site at www.express-scripts.com/corporate. RealPlayer or Windows Media Player is needed to listen to the webcast and free downloads of these players are available at the webcast site.

A slide presentation will be posted on Express Scripts' website. Following the conference call, both the slide presentation and the webcast will remain available on the Investor Information section of Express Scripts' website for 14 days.

About Express Scripts

Express Scripts ESRX manages more than one billion prescriptions each year for tens of millions of patients. On behalf of our clients – employers, health plans, unions and government health programs – we make use of prescription drugs safer and more affordable. Express Scripts uniquely combines three capabilities – behavioral sciences, clinical specialization and actionable data – to create Health Decision Science®, our innovative approach to help individuals make the best benefit choices, drug choices, pharmacy choices and health choices. Better decisions mean healthier outcomes.

Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery, specialty benefit management, benefit-design consultation, drug-utilization review, formulary management, and medical and drug data analysis services. The company also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services. 

For more information, visit Lab.Express-Scripts.com or follow @ExpressScripts on Twitter.